Emerald Advisers Inc Buys Avient Corp, Ultragenyx Pharmaceutical Inc, Ocular Therapeutix Inc, Sells Horizon Therapeutics PLC, TopBuild Corp, QTS Realty Trust Inc

• New Purchases: AVNT, RARE, OCUL, ARVN, HLI, FWRD, MEG, AIMC, SSB, FIZZ, RPAY, CRIS, COHU, FORM, LOB, AMWL, JAMF, JAMF, MMSI, PRTS, OC, PINS, AYX, SI, CNK, FLT, AMSC, UTZ, ZNGA, TTD, VSH, MPWR, EXAS, DMTK, ORGO, AEO, LEAF, TIG, GDRX,
• Added Positions: CMD, ARNA, CVET, VC, ONTO, TPTX, ORIC, TNET, PRFT, RAMP, DIOD, STMP, BRP, CCXI, FARO, DCPH, KPTI, EVER, SMCI, SMTC, AVRO, IMVT, UTHR, ATSG, SPNE, COLL, ATRC, DRNA, FTI, FOXF, SMG, PPBI, GDOT, SEAS, ITGR, CCK, MC, ROKU, LTHM, LITE, TMDX, APLT, SYNH, IAC, GNRC, XLRN, BLL, LNG, JPM, SPGI, MSFT, OSTK, PII, BKNG, WGO, PFPT, FB, DOCU, TWLO, ORRF, HEAR, PYPL, EEFT, CZNC, BMRA, GLPI, ARKG,
• Reduced Positions: HZNP, BLD, QTS, TWST, FRPT, MTH, GLUU, MRTX, CHDN, EHTH, ZGNX, MNR, MRCY, GFF, BHVN, BPMC, VRNS, TMHC, THG, PLNT, NFE, KTOS, TRHC, CHGG, PLMR, BRBR, SMPL, EVRI, PNFP, OCFC, FIVE, TTEK, CRDF, OYST, VICR, BBY, PSTG, TTWO, PLCE, MKTX, ALNY, XLNX, NEO, LHX, REPL, V, VIAV, VRSK, INCY, MODN, HD, SPLK, SPOT, ALRM, MRNA, RGLD, CRWD, CSGP, CDNS, CERN, FTV, ATEX, SRPT, AZO, ADI, MDB, MRBK, CNNE, PLAN, APH, AMZN, CHWY, ADBE, SBAC, BWXT, SHEN, STE, TER, XPER, TRMB, RPM, PEGA, CMG, VG, MATW, LULU, KLAC, KEYS, MTCH, EPAM, ENPH, NOW, HOLX, RNG, VEEV, DPZ, DLTR, ZEN, CTLT, HUBS,
• Sold Out: PS, SAIC, AJRD, PY9, LIVN, BDSI, MNKD, ASMB, ZZF, AGS, ADMS, VMC, EQIX, FTNT, ETSY, JKHY, LEN, PEN, BERY, REGN, HLT, WAL, WYNN, BEAT, AKAM, EQT, BNTX, CUBI, SCBH, INBK, VNT, ALE, NREF, BDTX, PMT, PINE, PSTL, STAG, AL, HRTG, PSN, BLUE, PLYM, IIPR, OMF, STAY, I4F, GCI, LNTH, NAVI, EBIX, MTX, MTZ, KLIC, JW.A, IVC, GTN, GME, FFIC, FRME, NCR, CUB, CRK, CLF, CFFI, BSTC, BDC, OZK, APOG, TBBK, ICFI, AAN, AAWW, STAR, WAB, VVI, UFPI, PAG, TDC, STC, SWBI, STBA, RYN, PLAB, GLT, OSUR, OSIS,

For the details of EMERALD ADVISERS INC's stock buys and sells, go to https://www.gurufocus.com/guru/emerald+advisers+inc/current-portfolio/portfolio

1. Chegg Inc (CHGG) - 816,648 shares, 2.52% of the total portfolio. Shares reduced by 8.01%
2. NeoGenomics Inc (NEO) - 1,350,805 shares, 2.48% of the total portfolio. Shares reduced by 1.07%
3. Freshpet Inc (FRPT) - 493,933 shares, 2.40% of the total portfolio. Shares reduced by 25.52%
4. Rapid7 Inc (RPD) - 694,335 shares, 2.14% of the total portfolio. Shares added by 0.16%
5. Varonis Systems Inc (VRNS) - 369,802 shares, 2.07% of the total portfolio. Shares reduced by 14.09%

Emerald Advisers Inc initiated holding in Avient Corp. The purchase prices were between $28.75 and $40.37, with an estimated average price of $35.48. The stock is now traded at around $38.430000. The impact to a portfolio due to this purchase was 1.09%. The holding were 792,730 shares as of 2020-12-31.

Emerald Advisers Inc initiated holding in Ultragenyx Pharmaceutical Inc. The purchase prices were between $84.4 and $177.39, with an estimated average price of $119.99. The stock is now traded at around $138.590000. The impact to a portfolio due to this purchase was 1.07%. The holding were 226,875 shares as of 2020-12-31.

Emerald Advisers Inc initiated holding in Ocular Therapeutix Inc. The purchase prices were between $8.04 and $22.95, with an estimated average price of $15.09. The stock is now traded at around $18.150000. The impact to a portfolio due to this purchase was 0.84%. The holding were 1,190,703 shares as of 2020-12-31.

Emerald Advisers Inc initiated holding in Arvinas Inc. The purchase prices were between $20.19 and $84.93, with an estimated average price of $35.2. The stock is now traded at around $75.440000. The impact to a portfolio due to this purchase was 0.75%. The holding were 257,940 shares as of 2020-12-31.

Emerald Advisers Inc initiated holding in Houlihan Lokey Inc. The purchase prices were between $59.43 and $70.1, with an estimated average price of $64.94. The stock is now traded at around $64.850000. The impact to a portfolio due to this purchase was 0.7%. The holding were 304,420 shares as of 2020-12-31.

Emerald Advisers Inc initiated holding in Forward Air Corp. The purchase prices were between $59.21 and $78.2, with an estimated average price of $69.72. The stock is now traded at around $71.690000. The impact to a portfolio due to this purchase was 0.64%. The holding were 244,059 shares as of 2020-12-31.

Emerald Advisers Inc added to a holding in Cantel Medical Corp by 2880.99%. The purchase prices were between $42.85 and $79.52, with an estimated average price of $59.19. The stock is now traded at around $78.970000. The impact to a portfolio due to this purchase was 0.76%. The holding were 292,554 shares as of 2020-12-31.

Emerald Advisers Inc added to a holding in Arena Pharmaceuticals Inc by 215.10%. The purchase prices were between $63.85 and $87.71, with an estimated average price of $74.84. The stock is now traded at around $74.240000. The impact to a portfolio due to this purchase was 0.66%. The holding were 364,392 shares as of 2020-12-31.

Emerald Advisers Inc added to a holding in Visteon Corp by 83.28%. The purchase prices were between $70.56 and $131.02, with an estimated average price of $106.46. The stock is now traded at around $127.480000. The impact to a portfolio due to this purchase was 0.37%. The holding were 187,861 shares as of 2020-12-31.

Emerald Advisers Inc added to a holding in Covetrus Inc by 267.75%. The purchase prices were between $24.45 and $31.59, with an estimated average price of $27.09. The stock is now traded at around $34.070000. The impact to a portfolio due to this purchase was 0.37%. The holding were 522,575 shares as of 2020-12-31.

Emerald Advisers Inc added to a holding in Onto Innovation Inc by 45.78%. The purchase prices were between $30.29 and $48.18, with an estimated average price of $40.4. The stock is now traded at around $54.050000. The impact to a portfolio due to this purchase was 0.26%. The holding were 509,882 shares as of 2020-12-31.

Emerald Advisers Inc added to a holding in ORIC Pharmaceuticals Inc by 60.92%. The purchase prices were between $20.32 and $39.8, with an estimated average price of $28.93. The stock is now traded at around $29.320000. The impact to a portfolio due to this purchase was 0.23%. The holding were 522,302 shares as of 2020-12-31.

Emerald Advisers Inc sold out a holding in Pluralsight Inc. The sale prices were between $14.74 and $21.31, with an estimated average price of $17.89.

Emerald Advisers Inc sold out a holding in Science Applications International Corp. The sale prices were between $73.32 and $99.65, with an estimated average price of $88.3.

Emerald Advisers Inc sold out a holding in Aerojet Rocketdyne Holdings Inc. The sale prices were between $32.42 and $52.97, with an estimated average price of $40.37.

Emerald Advisers Inc sold out a holding in Avient Corp. The sale prices were between $23.8 and $32.8, with an estimated average price of $29.23.

Emerald Advisers Inc sold out a holding in LivaNova PLC. The sale prices were between $46.62 and $68.74, with an estimated average price of $55.9.

Emerald Advisers Inc sold out a holding in BioDelivery Sciences International Inc. The sale prices were between $3.12 and $4.54, with an estimated average price of $3.86.